CIK 0001712762 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465211056
- Phone
- 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-01 | Edwards James Michael Chief Financial Officer | Purchase | +2,448 | 30,323 | ||
| 2022-08-31 | KNIGHT PETER S Director | Purchase | +8,163 | 22,448 | ||
| 2022-08-31 | Anderson Robert A. Director | Purchase | +4,081 | 4,081 | ||
| 2022-08-31 | DIAMOND STUART Director | Purchase | +4,081 | 4,081 | ||
| 2022-08-31 | Zannes Maria President, CEO | Purchase | +16,326 | 19,897 | ||
| 2022-08-31 | GIRGENTI STEVEN Executive Chairman | Purchase | +40,916 | 861,099 | ||
| 2022-08-31 | Rubin Gary D Director | Purchase | +16,326 | 1,584,144 |
Page 1 of 1 · 7 trades